Differential regulation of neurofibromin and p120 GTPase-activating protein by nutritionally relevant fatty acids

Nutrition and Cancer

Volumn 30, Issue 2, 1998, Pages 97-107

  Golubić, Mladen ^a   Harwalkar, Jyoti A ^a   Bryant, Sophia S ^b   Sundaram, Vidyodhaya ^a   Jove, Richard ^b   Lee, Joung H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; NEUROFIBROMIN; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; ONCOPROTEIN; POLYUNSATURATED FATTY ACID; STEARIC ACID;

ARTICLE; ENZYME ACTIVE SITE; ENZYME INHIBITION; ONCOGENE C H RAS; TRANSCRIPTION REGULATION;

EID: 0031968368     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635589809514648     Document Type: Article

References (56)

1. Lowy, DR, and Willumsen, BM: Function and regulation of Ras. Annu Rev Biochem 62, 851-891, 1993.
2. Katz, ME, and McCormick, F: Signal transduction from multiple Ras effectors. Curr Opin Genet Dev 7, 75-79, 1997.
3. Trahey, M, and McCormick, F: A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science 238, 542-545, 1987.
4. von Deimling, A, Krone, W, and Menon, GA: Neurofibromatosis type 1: pathology, clinical features and molecular genetics. Brain Pathol 5, 153-162, 1995.
5. Boguski, MS, and McCormick, F: Proteins regulating Ras and its relatives. Nature 366, 643-653, 1993.
6. Bos, JL: Ras oncogenes in human cancer: a review. Cancer Res 49, 4682-4689, 1989.
7. Chang, EH, Furth, ME, Scolnic, EM, and Lowy, DR: Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Nature 297, 479-481, 1982.
8. Stahle-Backdhal, M, Inoue, M, Zedenius, J, Sandstedt, B, Demarco, L, et al.: Decreased expression of Ras GTPase activating protein in human trophoblastic tumors. Am J Pathol 146, 1073-1078, 1995.
9. Sundaram, V, Lee, J, Harwalkar, J, Roudebush, M, Stein, DJ, et al.: Reduced expression of neurofibromin in human meningiomas. Br J Cancer 76, 747-756, 1997.
10. Friedman, E, Gejman, PV, Martin, GA, and McCormick, F: Nonsense mutations in the C-terminal SH2 region of the GTPase activation protein (GAP) gene in human tumours. Nature Genet 5, 242-247, 1993.
11. Golubic, M, Tanaka, K, Dobrowolski, S, Wood, D, Tsai, MH, et al.: The GTPase stimulatory activities of the neurofibromatosis type 1 and the yeast IRA2 proteins are inhibited by arachidonic acid. EMBO J 10, 2897-2903, 1991.
12. Tsai, M-H, Yu, C-L, Wei, S-F, and Stacey, DW: The effects of GTPase activating protein upon ras is inhibited by mitogenically responsive lipids. Science 243, 522-526, 1989.
13. Han, J-W, McCormick, F, and Macara, I: Regulation of Ras-GAP and the neurofibromatosis-1 gene product by eicosanoids. Science 252, 576-579, 1991.
14. Bollag, G, and McCormick, F: Differential regulation of rasGAP and neurofibromatosis gene product activities. Nature 351, 576-579, 1991.
15. Golubic, M, Roudebush, M, Dobrowolski, S, Wolfman, A, and Stacey, DW: Catalytic properties, tissue and intracellular distribution of neurofibromin. Oncogene 7, 2151-2159, 1992.
16. Field, JK, and Spandidos, DA: The role of ras and myc oncogenes in human solid tumors and their relevance in diagnosis and prognosis (review). Anticancer Res 10, 1-22, 1990.
17. Watson, DMA, Elton, RA, Jack, WJL, Dixon, JM, Chetty, U, et al.: The H-ras oncogene product p21 and prognosis in human breast cancer. Breast Cancer Res Treat 17, 161-169, 1990.
18. Gumerlock, PH, Poonamallee, UR, Meyers, FJ, and White, RW: Activated ras alleles in human carcinoma of prostate are rare. Cancer Res 51, 1632-1637, 1991.
19. Sun, X-F, Hatschek, T, Wingren, S, Stal, O, Carstensen, JM, et al.: Ras p21 expression in relation to histopathological variables and prognosis in colorectal adenocarcinoma. Acta Oncol 30, 933-939, 1991.
20. Forrester, K, Almoguera, C, Han, K, Grizzlw, WE, and Perucho, M: Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327, 298-303, 1987.
21. Kromhout, D: The importance of n-6 and n-3 fatty acids in carcinogenesis. Med Oncol Tumors Pharmacother 7, 173-176, 1990.
22. Birt, DF: The influence of dietary fat on carcinogenesis: lessons from experimental models. Nutr Rev 48, 1-5, 1990.
23. Rose, DP, Connolly, JM, Rayburn, J, and Coleman, M: Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice. JNCI 87, 587-592, 1995.
24. Wang, Y, Corr, JG, Thaler, HT, Tao, Y, Fair, WR, et al.: Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. JNCI 87, 1456-1466, 1995.
25. Henderson, M: International differences in diet and cancer incidence. Natl Cancer Inst Monogr 12, 59-63, 1992.
26. Cohen, LA: Lipids and cancer: an introduction. Lipids 27, 791-792, 1992.
27. Giovannucci, EJ, Rimm, EB, Colditz, GA, Stampfer, MJ, Ascherio, A, et al.: A prospective study of dietary fat and risk of prostate cancer. JNCI 85, 1571-1579, 1993.
28. Sumida, C, Graber, R, and Nunez, E: Role of fatty acids in signal transduction: modulators and messengers. Prostaglandins Leukot Essent Fatty Acids 48, 117-122, 1993.
29. Holian, O, and Nelson, R: Action of long-chain fatty acids on protein kinase C activity: comparison of ω-6 and ω-3 fatty acids. Anticancer Res 12, 975-980, 1992.
30. DeWille, JW, Waddell, K, Steinmeyer, C, and Farmer, SJ: Dietary fat promotes mammary tumorigenesis in MMTV/v-Ha-ras transgenic mice. Cancer Lett 69, 59-66, 1993.
31. 2 levels in DMBA-treated rats. Anticancer Res 9, 1169-1174, 1989.
32. Singh, J, Hamid, R, and Reddy, BR: Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res 57, 253-258, 1997.
33. Yoder-Hill, J, Golubic, M, and Stacey, DW: A conserved region of c-Ha-Ras is required for efficient GTPase stimulation by GTPase activating protein but not neurofibromin. J Biol Chem 270, 27615-27621, 1995.
34. Bryant, SS, Mitchell, AL, Collins, F, Miao, W, Marshall, M, et al.: N-terminal sequences contained in the src homology 2 and 3 domains of p120 GTPase-activating protein are required for full catalytic activity toward Ras. J Biol Chem 271, 5195-5199, 1996.
35. Rose, DP, Connolly, JM, and Liu, X-H: Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro. Cancer Res 54, 6557-6562, 1994.
36. Cave, WT: Dietary n-3 (ω-3) polyunsaturated fatty acid effects on animal tumorigenesis. FASEB J 5, 2160-2166, 1991.
37. Gonzalez, MJ, Schemmel, RA, Dugan, L, Gray, JI, and Welsch, CW: Dietary fish oil inhibits human breast carcinoma growth: a function of increased lipid peroxidation. Lipids 28, 827-832, 1993.
38. 1 phase cyclin-dependent kinase without altering mitogen-activated protein kinase stimulation. J Biol Chem 271, 9376-9383, 1996.
39. ++ mobilization by arachidonic acid. J Biol Chem 261, 3501-3511, 1986.
40. 2 activity in the human neutrophil. Biochem J 291, 825-831, 1993.
41. Sermon, BA, Eccleston, JF, Skinner, RH, and Lowe, PN: Mechanism of inhibition by arachidonic acid of the catalytic activity of Ras GTPase-activating protein. J Biol Chem 271, 1566-1572, 1996.
42. Glick, J, Santoyo, G, and Casey, PJ: Arachidonate and related unsaturated fatty acids selectively inactivate the guanine nucleotide-binding regulatory protein Gz. J Biol Chem 271, 2949-2954, 1996.
43. c-Ha-ras-GMP-PNP with full-length neurofibromin and GTPase-activating protein. Oncogene 8, 637-643, 1993.
44. Downward, J: Control of ras activation. Cancer Surv 27, 87-100, 1996.
45. Scheffzek, K, Ahmadian, MR, Kabash, W, Weismueller, L, Lautwein, A, et al.: The Ras-RasGAP complex: structural basis for the GTPase activation and its loss in oncogenic Ras mutants. Science 277, 333-338, 1997.
46. Bandyopadhyay, GK, Imagawa, W, and Nandi, S: Role of GTP-binding proteins in the polyunsaturated fatty acid stimulated proliferation of mouse mammary epithelial cells. Prostaglandins Leukot Essent Fatty Acids 52, 151-158, 1995.
47. Lu, J, Jiang, C, Fontaine, S, and Thompson, HJ: ras may mediate mammary cancer promotion by high fat. Nutr Cancer 23, 283-290, 1995.
48. Daston, MM, Scrable, H, Norlund, M, Sturbaum, AK, Nissen, LM, et al.: The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells and oligodendrocytes. Neuron 8, 415-428, 1992.
49. Murphy, MG: Dietary fatty acids and membrane protein function. J Nutr Biochem 1, 68-79, 1991.
50. Clandinin, MT, Cheema, S, Field, CJ, Garg, ML, Venkatraman, J, et al.: Dietary fat: exogenous determination of membrane structure and cell function. FASEB J 5, 2761-2769, 1991.
51. Lai, LTY, and German, JB: Modulation of fatty acid composition in murine brain by dietary unsaturated fats. J Nutr Biochem 4, 463-471, 1993.
52. Reddy, BS, and Maeura, Y: Tumor promotion by dietary fat in azoxymethane-induced colon carcinogenesis in female F344 rats: influence of amount and source of dietary fat. JNCI 72, 745-750, 1984.
53. Cohen, LA, Thompson, DO, Maeura, Y, Choi, K, Blank, ME, et al.: Dietary fat and mammary cancer. I. Promoting effects of different dietary fats on N-nitrosomethylurea-induced rat mammary tumorigenesis. JNCI 77, 33-42, 1986.
54. Takeshita, M, Ueda, H, Shirabe, K, Higuch, Y, and Yosida, S: Lack of promotion of colon carcinogenesis by high-oleic safflower oil. Cancer 79, 1487-1493, 1997.
55. Wynder, EL, Cohen, LA, Muscat, JE, Winters, B, Dwyer, JT, et al.: Breast cancer: weighing the evidence for a promoting role of dietary fat. JNCI 89, 766-775, 1997.
56. Bautista, D, Obrador, A, Moreno, V, Cabeza, E, Canet, R, et al.: Ki-ras mutation modifies the protective effect of dietary monounsaturated fat and calcium on sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev 6, 57-61, 1997.